Regulation of phospholamban and sarcoplasmic reticulum Ca 2+-ATPase by atorvastatin: Implication for cardiac hypertrophy

Archives of Pharmacal Research

Volumn 30, Issue 5, 2007, Pages 596-602

  Kang, Lan ^a   Fang, Qiang ^a,b   Hu, Shen Jiang ^a  

^a ZHEJIANG UNIVERSITY SCHOOL OF MEDICINE   (China)

^b Immunology Division   (China)

Author keywords

Atorvastatin; Phospholamban; Sarcoplasmic reticulum Ca2+ ATPase; Spontaneously hypertensive rat

Indexed keywords

EID: 34249786850     PISSN: 02536269     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF02977654     Document Type: Article

References (23)

1. Aoyagi, T., Yonekura, K., and Eto, Y., The sarcoplasmic reticulumCa-ATPase (SERCA2) gene promoter activity is decreased in response to severe left ventricular pressure-overload hypertrophy in rat hearts. J. Mol. Cell. Cardiol., 31, 919-926 (1999).
2. 2+ Adenosine Triphosphatase by Phospholambanand Sarcolipin: Implication for Cardiac Hypertrophy and Failure. Trends. Cardiovasc. Med., 13, 152-157 (2003).
3. 2+ affinity by phospholamban in transgenic hearts overexpressing a non-phosphorylatable form of phospholamban. J. Biol. Chem., 275, 12129-12135 (2000).
4. Baker, D. L., Hashimoto, K., Grupp, I. L., Ji, Y., Reed, T., and Loukianov, E., Targeted overexpression of the sarcoplasmic reticulum Ca2+-ATPase increases cardiac contractility in transgenic mouse hearts. Circ. Res., 83, 1205-1214 (1998).
5. Currie, S. and Smith, G. L., Enhanced phosphorylation of phospholamban and downregulation of sarco/endoplasmic reticulum Ca2+ ATPase type 2 (SERCA 2) in cardiac sarcoplasmic reticulum from rabbits with heart failure. Cardiovasc. Res., 41, 135-146 (1999).
6. 2+ in cardiac hypertrophy. Cardiovasc. Res., 62, 538-547 (2004).
7. Hasenfuss, G., Alterations of calcium-regulatory proteins in heart failure. Cardiovasc. Res., 37, 279-289 (1998).
8. Hunter, J. J. and Chien, K. R., Signaling pathways for cardiac hypertrophy and failure. N. Engl. J. Med., 341, 1276-1283 (1999).
9. Hasegawa, H., Yamamoto, R., Takano, H., Mizukami, M., Asakawa, M., and Nagai, T., 3-Hydroxy-3-methylglutaryl coenzyme A reductase inhibitors prevent the development of cardiac hypertrophy and heart failure in rats. J. Mol. Cell. Cardiol., 35, 953-960 (2003).
10. 2+ ATPase gene in the heart of transgenic mice accelerates calcium transients and cardiac relaxation. J. Clin. Invest., 100, 380-389 (1997).
11. LaPointe, M. C., Deschepper, C. F., Wu, J. P., and Gardner, D. G., Extracellular calcium regulates expression of the gene for atrial natriuretic factor. Hypertension., 15, 20-28 (1990).
12. Lee, T. M., Chou, T. F., and Tsai, C. H., Effects of pravastatin on cardiomyocyte hypertrophy and ventricular vulnerability in normolipidemic rats after myocardial infarction. J. Mol. Cell. Cardiol., 35, 1449-1459 (2003).
13. Molkentin, J. D. and Dorn II, I. G., Cytoplasmic signaling pathways that regulate cardiac hypertrophy. Annu. Rev. Physiol., 63, 391-426 (2001).
14. ..and excitation-contraction coupling in hypertrophic rat ventricular myocytes. Am. J. Physiol., 1274, H1348-H1360 (1998).
15. Matsui, H., MacLennan, D. H., Alpert, N. R., and Periasamy, M., Sarcoplasmic reticulum gene expression in pressure overload-induced cardiac hypertrophy in rabbit. Am. J. Physiol., 268, C252-C258 (1995).
16. Nakayama, H., Otsu, K., and Yamaguchi, O., Cardiac-specific overexpression of a high Ca2+_ affinity mutant of SERCA2a attenuatesin vivo pressure overload cardiac hypertrophy. FASEB. J., 17, 61-63 (2002).
17. +) homeostasis and cardiac contractility. J. Mol. Cell. Cardiol., 33, 1053-1063 (2001).
18. +-ATPase during progression ofleft ventricular hypertrophy. Am. J. Physiol., 272, H2416-H2424 (1997).
19. +-uptake during the development of left ventricular hypertrophy. Biochem. Pharm., 65, 933-939 (2003).
20. Van Heugten, H. A. A., van Setten, M. C., Eizema, K., Verdouw, P. D., and Lamers, J. M. J., Sarcoplasmic reticulum Ca2+ ATPase promoter activity during endothelin-1 induced hypertrophy of cultured rat cardiomyocytes. Cardiovasc. Res., 37, 503-514 (1998).
21. +/calmodulin-dependent protein kinase II in cardiac hypertrophy and heart failure. Cardiovasc. Res., 63, 476-486 (2004).
22. + ATPase gene expression in renal hypertensive rats: dosedependent effects of ACE inhibition and AT1-receptor blockade. Cardiovasc. Res., 31, 758-768 (1996).
23. Zhai, J., Schmidt, A. G., and Hoit, B. D., Cardiac-specific overexpression of a superinhibitory pentameric phospholamban mutant enhances inhibition of cardiac function in vivo. J. Biol. Chem., 275, 538-544 (2000).